- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04496934
Fysisk aktivitet som tilleggsbehandling for opioidsubstitusjonsterapi
In terms of research, it is documented that exercise has a positive effect on mental disorders. Studies have shown positive correlations between physical and mental health, also among substance users. Such a study has never been performed on patients in opioid substitution therapy (OST). Documentation on the physical health of patients and the effect of exercise is very limited. Treatment of substance users is a research area with insufficient knowledge about certain treatment effects. It is important that a treatment can both support and promote the user's own resources and efforts to change their habits of substance use.
The objective of this project is to examine the effect of exercise for OST patients, measured in relation to cognitive function and physical form. The target group consists of OST patients from 18 years of age and up, of both sexes, and on stable medication. At least 60 participants should complete the project, which is designed as a controlled randomized study (RCT). Participants in the intervention group start to exercise immediately after baseline testing. Participants in the control group are on a waiting list and will start to exercise after twelve weeks. Both groups undergo testing at baseline, after three, six and 12 months. Testing consists of two parts: A battery of cognitive and psychosocial assessments and an assessment of physical variables.
The research questions of this project are important in a public health perspective. Generated knowledge can be quickly applied to local treatment institutions in Norway.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Bergen, Norge
- Haukeland University Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Participants must sign a informed consent form
- Must be participating in an opioid substitution program
- Must be on a steady fixed dose of medication
- Must be at least 18 years of age
Exclusion Criteria:
- Pregnancy
- Being in opioid substitution program for less than three months
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention
Exercise intervention |
Exercise of choice with a training contact: 3 hrs/week, total of 12 weeks. |
|
Aktiv komparator: Control
The control group is a waiting list group. The participants will receive exercise intervention after twelve weeks of treatment as usual. |
Exercise of choice with a training contact: 3 hrs/week, total of 12 weeks. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Height and weight
Tidsramme: 12 weeks
|
Weight and height will be combined to report BMI in kg/m^2 |
12 weeks
|
|
Endurance
Tidsramme: 12 weeks
|
Ventilatory threshold/VO2max (endurance test on treadmill) |
12 weeks
|
|
Strength
Tidsramme: 12 weeks
|
Push-ups (maximal test where the participants perform a maximum number of correct push-ups) |
12 weeks
|
|
Balance
Tidsramme: 12 weeks
|
Stork Balance Test (timed test where the goal is to keep one's balance as long as possible) |
12 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Alcohol use
Tidsramme: 12 weeks
|
AUDIT-E |
12 weeks
|
|
Drug use
Tidsramme: 12 weeks
|
DUDIT-E |
12 weeks
|
|
Executive functions
Tidsramme: 12 weeks
|
Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) |
12 weeks
|
|
Satisfaction with life
Tidsramme: 12 weeks
|
Satisfaction With Life Scale (SWLS) Values/scores:
Results (sum of scores/values): 31 - 35 Extremely satisfied 26 - 30 Satisfied 21 - 25 Slightly satisfied 20 Neutral 15 - 19 Slightly dissatisfied 10 - 14 Dissatisfied 5 - 9 Extremely dissatisfied The higher the score the better the outcome. |
12 weeks
|
|
Sleep quality
Tidsramme: 12 weeks
|
Pittsburgh Sleep Quality Index (PSQI) |
12 weeks
|
|
Attention
Tidsramme: 12 weeks
|
Connors Continuous Performance Test (CPT 3) |
12 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Studieleder: Asgeir Mamen, PhD, Kristiania University College
- Studieleder: Lars Thore Fadnes, PhD, University of Bergen
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2013/00731
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .